
X
Gilead rescinds orphan status request for COVID-19 drug
https://pharmaphorum.com/news/gilead-rescinds-orphan-status-request-for-covid-19-drug/
‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.